Sharkovska, Yuliya <br/><br/>
Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage.  [electronic resource] 

 -  Clinical laboratory  2011 
 - 507-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1433-6510 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--drug therapy<br/>Albuminuria--etiology<br/>Animals<br/>Aspartic Acid Endopeptidases--antagonists & inhibitors<br/>Constriction<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical<br/>Endothelin-Converting Enzymes<br/>Enzyme Inhibitors--pharmacology<br/>Glomerulosclerosis, Focal Segmental--etiology<br/>Hypertension--chemically induced<br/>Kidney--blood supply<br/>Kidney Failure, Chronic--drug therapy<br/>Male<br/>Metalloendopeptidases--antagonists & inhibitors<br/>NG-Nitroarginine Methyl Ester--toxicity<br/>Nephrectomy<br/>Neprilysin--antagonists & inhibitors<br/>Rats<br/>Rats, Wistar<br/>Reperfusion Injury--complications